BioMed Research International / 2015 / Article / Tab 1

Research Article

Modern Evaluation of Liquisolid Systems with Varying Amounts of Liquid Phase Prepared Using Two Different Methods

Table 1

Composition of liquisolid tablets.

SampleRosuvastatinPEG 400Neusilin US2Aerosil 200Kollidon CL-FMg stearateLactose
mg%mg%mg%mg%mg%mg%mg%

40%w101.512318.9332.551.26.51.032.55.06.51.0139.021.40.4
50%w101.512318.9266.040.95.30.832.55.06.51.0206.731.80.5
60%w101.512318.9221.734.14.40.732.55.06.51.0251.938.80.6
70%w101.512318.9190.029.23.80.632.55.06.51.0284.243.70.7
80%w101.512318.9166.425.63.30.532.55.06.51.0308.347.40.8
90%w101.512318.9147.822.73.00.532.55.06.51.0327.250.30.9
100%w101.512318.9133.020.52.70.432.55.06.51.0342.352.71.0
110%w101.512318.9121.018.62.40.432.55.06.51.0354.654.61.1
120%w101.512318.9110.817.12.20.332.55.06.51.0365.056.21.2

means liquid load factor.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.